Fischer, M., Wulff, B., Baruchel, S., Berlanga, P., Trahair, T., Mechinaud, F., Schulte, J., Modak, S., Merks, J., Zwaan, C., Marshall, L., Casanova, M., Branle, F., Malet, I., Emeremni, A., & Geoerger, B. (n.d.). phase 1 study of ceritinib in pediatric patients with malignancies harboring activated anaplastic lymphoma kinase (ALK): Safety, pharmacokinetics and efficacy results from the fed population. European journal of cancer, 69, S49–S50. http://access.bl.uk/ark:/81055/vdc_100039473340.0x000033